Toggle navigation
Home
Search
Services
Blog
Contact
About
Phase I Single and Multiple-Dose Safety and Pharmacokinetic Clinical S-261025118
University of Pennsylvania Inc
Search grants from University of Pennsylvania Inc
Share this grant:
:
:
Abstract
Funding
Institution
Related projects
Comments
Recent in Grantomics:
Fred Hutchinson Cancer Research Center
vs. funders. Who wins?
Read more...
How should you pick the next fundable research topic?
Read more...
Recently viewed grants:
Developing a Peer Coach Program to Improve Adherence Rates for Colonoscopy
Role of Platelet derived growth factor receptor-a in Liver Patho-biology
Early Quantitative Characterization of Reciprocal Social Behavior
Community Partnership Prevention in Springfield, MO
Cancer and Leukemia Group B
Recently added grants:
Regulation of Niche Cell Differentiation to Sustain Intestinal Stem Cell Regeneration Against Gut Inflammation
Chromosomal death due to misincorporation of wrong material into DNA
Principal Component Pursuit to Assess Exposure to Environmental Mixtures in Epidemiologic Studies
Michigan State University PREP: Increasing Underrepresented Minority Representation in Biomedical Sciences
The link between oral bacteria and gut disease
Abstract
Funding Agency
Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research and Development Contracts (N01)
Project #
N01CA025118-000
Application #
6688659
Study Section
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
2002
Total Cost
Indirect Cost
Institution
Name
University of Pennsylvania Inc
Department
Type
DUNS #
City
State
Country
Zip Code
Related projects
NIH 2003
N01 CA
Phase I Single and Multiple-Dose Safety and Pharmacokinetic Clinical S-261025118
/ University of Pennsylvania Inc
NIH 2002
N01 CA
Phase I Single and Multiple-Dose Safety and Pharmacokinetic Clinical S-261025118
/ University of Pennsylvania Inc
Comments
Be the first to comment on this grant